I agree that this site is using cookies. You can find further informations here.
X
Krägeloh‐Mann, Ingeborg
93  results:
OpenAccess-fulltext X
Search for persons X
?
1

Recognizing early MRI signs (or their absence) is crucial i..:

Schoenmakers, Daphne H ; Beerepoot, Shanice ; Krägeloh‐Mann, Ingeborg...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9735365/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
2

Long‐term disease course of two patients with multiple sulf..:

Beck‐Wödl, Stefanie ; Kehrer, Christiane ; Harzer, Klaus...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7932862/.  , 2020
Link: http://www.ncbi.nlm.nih...
 
?
3

Clinical application of advanced MR methods in children: po..:

Wilke, Marko ; Groeschel, Samuel ; Lorenzen, Anna...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6243383/.  , 2018
Link: http://www.ncbi.nlm.nih...
 
?
4

Demyelination load as predictor for disease progression in ..:

Strölin, Manuel ; Krägeloh‐Mann, Ingeborg ; Kehrer, Christiane..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5454396/.  , 2017
Link: http://www.ncbi.nlm.nih...
 
?
5

Additional file 1 of Recommendations for optimal interdisci..:

Holm Graessner ; Carola Reinhard ; Tobias Bäumer...
doi:10.6084/m9.figshare.25210645.v1.  , 2024
Link: https://doi.org/10.6084/..
 
?
6

Additional file 1 of Recommendations for optimal interdisci..:

Holm Graessner ; Carola Reinhard ; Tobias Bäumer...
doi:10.6084/m9.figshare.25210645.v1.  , 2024
Link: https://doi.org/10.6084/..
 
?
7

Core protocol development for phase 2/3 clinical trials in ..:

Daphne H. Schoenmakers ; Prisca S. Leferink ; Adeline Vanderver...
https://doi.org/10.1186/s12883-023-03354-9.  , 2023
Link: https://doi.org/10.1186/..
 
?
8

Core protocol development for phase 2/3 clinical trials in ..:

Schoenmakers, Daphne H ; Leferink, Prisca S ; Vanderver, Adeline...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10433679/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
9

Growth of a cohort of very low birth weight and preterm inf..:

Michaelis, Isabel Alexandra ; Krägeloh-Mann, Ingeborg ; Mazinu, Mikateko.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9889837/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
10

MR-spectroscopy in metachromatic leukodystrophy: A model fr..:

Joana Feldmann ; Pascal Martin ; Benjamin Bender...
http://www.sciencedirect.com/science/article/pii/S2213158222003618.  , 2023
Link: https://doi.org/10.1016/..
 
?
11

Growth of a cohort of very low birth weight and preterm inf..:

Isabel Alexandra Michaelis ; Ingeborg Krägeloh-Mann ; Mikateko Mazinu.
https://www.frontiersin.org/articles/10.3389/fped.2022.1075645/full.  , 2023
Link: https://doi.org/10.3389/..
 
?
12

Human COQ4 deficiency: delineating the clinical, metabolic ..:

Laugwitz, Lucia ; Seibt, Annette ; Herebian, Diran...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9807242/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
13

Identification of neurodegeneration indicators and disease ..:

Lucia Laugwitz ; Laimdota Zizmare ; Vidiyaah Santhanakumaran...
https://doi.org/10.1002/jmd2.12273.  , 2022
Link: https://doi.org/10.1002/..
 
?
14

The European Reference Network for Rare Neurological Diseas..:

Reinhard, Carola ; Bachoud-Lévi, Anne-Catherine ; Bäumer, Tobias...
https://www.frontiersin.org/articles/10.3389/fneur.2020.616569/full#supplementary-material.  , 2022
Link: https://doi.org/10.18725..
 
?
15

Therapy Trial Design in Vanishing White Matter: An Expert C..:

van der Knaap, Marjo S ; Bonkowsky, Joshua L ; Vanderver, Adeline...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8811717/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
1-15